Cogstate Limited (CGS.AX) is currently considered halal (Sharia-compliant), per In-house ratio engine (last assessed 2026-08-28). See the full ratio breakdown and business-activity screen below for the reasoning.
Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2026-06-30. CGS.AX files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.
Business activity: cleared (no excluded categories detected)
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.19% | 30.00% | Pass |
| Interest-bearing investments | 9.24% | 30.00% | Pass |
| Non-permissible income | 1.51% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.92% | 33.00% | Pass |
| Interest-bearing investments | 44.55% | 33.00% | Fail |
| Non-liquid assets | 29.87% | at least 20.00% | Pass |
| Non-permissible income | 1.51% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.92% | 33.33% | Pass |
| Cash + interest-bearing securities | 44.55% | 33.33% | Fail |
| Accounts receivable | 70.13% | 33.33% | Fail |
| Non-permissible income | 1.51% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.92% | 33.33% | Pass |
| Cash + interest-bearing securities | 44.55% | 33.33% | Fail |
| Accounts receivable | 70.13% | 50.00% | Fail |
| Non-permissible income | 1.51% | 5.00% | Pass |
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.31% | 33.00% | Pass |
| Cash + interest-bearing securities | 14.87% | 33.00% | Pass |
| Accounts receivable | 8.53% | 33.00% | Pass |
| Non-permissible income | 1.51% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.34% | 33.00% | Pass |
| Cash + interest-bearing securities | 16.62% | 49.00% | Pass |
| Accounts receivable | 9.54% | 49.00% | Pass |
| Non-permissible income | 1.51% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.34% | 33.33% | Pass |
| Cash + interest-bearing securities | 16.62% | 33.33% | Pass |
| Accounts receivable | 26.16% | 49.00% | Pass |
| Non-permissible income | 1.51% | 5.00% | Pass |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 53.20 | NEUTRAL |
| Stochastic %K (14) | 14.81 | BUY |
| CCI (20) | -25.07 | NEUTRAL |
| Williams %R (14) | -85.19 | BUY |
| MACD (12,26,9) | -0.02 | SELL |
| ROC (10) | -4.17 | SELL |
| Momentum (10) | -0.13 | SELL |
| EMA (10) | 3.03 | SELL |
| SMA (10) | 3.05 | SELL |
| EMA (20) | 2.98 | BUY |
| SMA (20) | 3.02 | SELL |
| EMA (30) | 2.93 | BUY |
| SMA (30) | 2.89 | BUY |
| EMA (50) | 2.84 | BUY |
| SMA (50) | 2.79 | BUY |
| EMA (100) | 2.70 | BUY |
| SMA (100) | 2.67 | BUY |
| EMA (200) | 2.54 | BUY |
| SMA (200) | 2.45 | BUY |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Health Information Services
Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. The company offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, including Alzheimer's disease and dementia, preclinical Alzheimer's disease, pediatrics and rare disease, Parkinson's disease, multiple sclerosis, schizophrenia, oncology, safety, and sleep and mood disorders. It also designs and provides quality assurance services in clinical trials focused on the administration, scoring, and recording of conventional brain health assessments. In addition, it develops a tool for primary care physicians and/or hospitals to assess cognitive decline. Its technology and associated services are used to quantify the effect of disease and drugs, devices, or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The company serves biopharmaceutical companies, academic institutions, physicians, and patients. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
Background via Yahoo Finance — informational, not part of the verdict.
Peer movement computing — it will appear here on its own.
NO DATA 0 buys · 0 sells
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.
